All Studies Meta Analysis

Relationship of serum zinc levels with severity and clinical presentation of COVID-19

Haji et al., Infectious Diseases, 22:2

Jun 2022

Post
Facebook

Source PDF All Studies Meta AnalysisMeta

Download Image

Zinc for COVID-19

2nd treatment shown to reduce risk in July 2020, now with p = 0.00000032 from 46 studies, recognized in 17 countries.

Lower risk for mortality, ventilation, hospitalization, progression, recovery, and viral clearance.

No treatment is 100% effective. Protocols combine treatments.

5,100+ studies for 109 treatments. c19early.org

Prospective study of 150 COVID-19 patients and 50 healthy controls in Iraq showing lower serum zinc levels associated with more severe COVID-19 outcomes. Patients with zinc deficiency (<0.7 mg/L) had longer recovery periods and higher rates of hospitalization compared to those with sufficient or high zinc levels. 40% of COVID-19 patients were zinc deficient.

Important missing comments or errors? Let us know.

risk of hospitalization, 65.6% lower, RR 0.34, p < 0.001, high zinc levels (≥0.7mg/L) 16 of 90 (17.8%), low zinc levels (<0.7mg/L) 31 of 60 (51.7%), NNT 3.0.

Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates

Haji et al., 28 Jun 2022, retrospective, Iraq, peer-reviewed, 2 authors.

This Paper Zinc All

Relationship of serum zinc levels with severity and clinical presentation of COVID-19

H A Haji, M A Al-Rikabi

Infekcionnye bolezni, doi:10.20953/1729-9225-2024-2-87-91

О р и

Заключение При проведении дополнительных исследований цинк может стать экономически эффективной терапией для COVID-19. Информация о финансировании Финансирование данной работы не проводилось. Financial support No financial support has been provided for this work. Конфликт интересов Авторы заявляют об отсутствии конфликта интересов. Conflict of interests The authors declare that there is no conflict of interest. Информированное согласие При проведении исследования было получено информированное согласие пациентов. Informed consent In carrying out the study, written informed consent was obtained from all patients. Информация о соавторе: Майтхам Али Аль-Рикаби, кафедра клинической фармации, фармацевтический колледж, Университет Басры, Басра, Ирак Information about co-author: Maitham Ali Al-Rikabi, Department of Clinical Pharmacy, College of Pharmacy, University of Basrah, Basrah, Iraq

References

Akira, Uematsu, Takeuchi, Pathogen recognition and innate immunity, Cell, doi:10.1016/j.cell.2006.02.015

Arthur, Mckenziey, Beckett, Immunity enhanced by trace elements

Chen, Zhou, Dong, Qu, Gong et al., Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet, doi:10.1016/S0140-6736(20)30211-7

Devaux, Rolain, Raoult, ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome, J Microbiol Immunol Infect, doi:10.1016/j.jmii.2020.04.015

Elham, Azam, Azam, Mostafa, Nasrin et al., Serum vitamin D, calcium, and zinc levels in patients with COVID-19, Clin Nutr ESPEN, doi:10.1016/j.clnesp.2021.03.040

Gammoh, Rink, Zinc in infection and inflammation, Nutrients, doi:10.3390/nu9060624

Huang, Wang, Li, Ren, Zhao et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, doi:10.1016/S0140-6736(20)30183-5

Jain, Chaurasia, Sengar, Singh, Mahor et al., Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers, Sci Rep, doi:10.1038/s41598-020-77093-z

Jothimani, Kailasam, Danielraj, Nallathambi, Ramachandran et al., COVID-19: Poor outcomes in patients with zinc deficiency, Int J Infect Dis, doi:10.1016/j.ijid.2020.09.014

Ko, Morihara, Shibata, Yamauchi, Fukuda et al., Factors attenuating zinc deficiency improvement in direct-acting antiviral agent-treated chronic hepatitis C virus infection, Nutrients, doi:10.3390/nu10111620

Kumar, Kubota, Since January

Lian, Zang, Wei, Ye, Hu et al., The zinc-finger protein ZCCHC3 binds RNA and facilitates viral RNA sensing and activation of the RIG-Ilike receptors, Immunity, doi:10.1016/j.immuni.2018.08.014

Ong, Pérusse, Impact of nutritional epigenomics on disease risk and prevention: introduction, J Nutrigenet Nutrigenomics, doi:10.1159/000334813

Overbeck, Rink, Haase, Modulating the immune response by oral zinc supplementation: a single approach for multiple diseases, Arch Immunol Ther Exp (Warsz), doi:10.1007/s00005-008-0003-8

Pecora, Persico, Argentiero, Neglia, Esposito, The role of micronutrients in support of the immune response against viral infections, Nutrients, doi:10.3390/nu12103198

Rahman, Idid, Can Zn be a critical element in COVID-19 treatment?, Biol Trace Elem Res, doi:10.1007/s12011-020-02194-9

Read, Obeid, Ahlenstiel, Ahlenstiel, The role of zinc in antiviral immunity, Adv Nutr, doi:10.1093/advances/nmz013

Singh, Can vitamins, as epigenetic modifiers, enhance immunity in COVID-19 patients with non-communicable disease?, Curr Nutr Rep, doi:10.1007/s13668-020-00330-4

Velthuis, Van Den Worm, Sims, Baric, Snijder et al., Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture, PLoS Pathog, doi:10.1371/journal.ppat.1001176

Wessels, Rolles, Rink, The potential impact of zinc supplementation on COVID-19 pathogenesis, Front Immunol, doi:10.3389/fimmu.2020.01712

Wong, Lam, Wu, Ip, Lee et al., Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome, Clin Exp Immunol, doi:10.1111/j.1365-2249.2004.02415.x

Wu, Mcgoogan, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention, JAMA, doi:10.1001/jama.2020.2648

Xue, Moyer, Peng, Wu, Hannafon et al., Chloroquine is a zinc ionophore, PLoS One, doi:10.1371/journal.pone.0109180

Download Image

Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.

Submit

Post

@CovidAnalysis

FAQ

Public domain CC0 1.0